La vendita allo scoperto per Universal Music Group dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Universal Music Group. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Universal Music Group (OTC:UNVGY) Azioni, Report sulle vendite allo scoperto

Universal Music is the largest of the three major record companies. Recorded music accounts for most of the firm's revenue, with the segment housing more than a dozen record labels, including notable names like Interscope, Capital Music, Motown Records, and Def Jam. Some of the most successful current artists signed to record deals with Universal include Taylor Swift, Drake, The Weeknd, and Morgan Wallen. Most of Universal's remaining revenue comes from its publishing segment, which generates revenue for songwriters and composers, including some of Universal's recording artists as well as songwriters and composers who do not record music themselves or are attached to other labels. Universal's publishing group has nearly 4.5 million owned or administered titles in its catalog.

UNIVERSAL MUSIC GRP U/ADR by UNIVERSAL MUSIC GROUP

Universal Music Group NV

Macro Economic Events

News

Econ #s

Economics

EIA Weekly Distillates Stocks 2.947M Barrel Build Vs 1.500M Barrel Draw Est.; 0.977M Barrel Draw Prior

Iron Mountain (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRM#NYSE">IRM</a>) has outperformed the market over the past 5 years by 15.97% on an annualized basis producing an average annual return of 29.67%. Currently, Iron Mountain has a market capitalization of $37.08 billion. 
Buying $100 In IRM: If an investor had bought $100 of IRM stock 5 years ago, it would be worth $364.41 today based on a price of $126.40 for IRM at the time of writing.
<h3>Iron Mountain's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730907021_0_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Iron Mountain 5 Years Ago Would Be Worth This Much Today

Williams Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) has outperformed the market over the past 5 years by 6.16% on an annualized basis producing an average annual return of 19.86%. Currently, Williams Companies has a market capitalization of $66.91 billion. 
Buying $1000 In WMB: If an investor had bought $1000 of WMB stock 5 years ago, it would be worth $2,469.20 today based on a price of $53.05 for WMB at the time of writing.
<h3>Williams Companies's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730907016_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today

Wells Fargo analyst Brandon Couillard maintains Bruker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) with a Overweight and lowers the price target from $78 to $75.

Price Target

Analyst Ratings

BRKR

Wells Fargo Maintains Overweight on Bruker, Lowers Price Target to $75

Macro Notification

General

USA Crude Oil Inventories 2.149M Barrel Build Vs 0.300M Barrel Build Est.; 0.515M Barrel Draw Prior

Susquehanna analyst Mehdi Hosseini maintains GLOBALFOUNDRIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) with a Neutral and lowers the price target from $50 to $48.

Susquehanna Maintains Neutral on GLOBALFOUNDRIES, Lowers Price Target to $48

RBC Capital analyst Jimmy Shan maintains Colliers Intl Gr (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CIGI#TSX">CIGI</a>) with a Outperform and lowers the price target from C$174 to C$170.

CIGI

TSX:CIGI

RBC Capital Maintains Outperform on Colliers Intl Gr, Lowers Price Target to C$170

Wells Fargo analyst Vik Chopra maintains Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) with a Overweight and raises the price target from $78 to $88.

GMED

Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $88

RBC Capital analyst Maurice Choy reiterates Fortis (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FTS#TSX">FTS</a>) with a Sector Perform and maintains C$65 price target.

Reiteration

TSX:FTS

RBC Capital Reiterates Sector Perform on Fortis, Maintains C$65 Price Target

Wells Fargo analyst Vik Chopra maintains Masimo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASI#NASDAQ">MASI</a>) with a Overweight and raises the price target from $160 to $171.

MASI

Wells Fargo Maintains Overweight on Masimo, Raises Price Target to $171

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 1,200 points on Wednesday.
The Dow traded up 2.90% to 43,445.79 while the NASDAQ rose 2.03% to 18,813.03. The S&amp;P 500 also rose, gaining, 1.77% to 5,884.97.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/11/41774936/how-to-earn-500-a-month-from-qualcomm-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Qualcomm Stock Ahead Of Q4 Earnings</a>
Leading and Lagging Sectors Financial shares surged by 4.4% on Tuesday.
In trading on Tuesday, real estate shares fell by 1.8%.
Top Headline
Former President Donald Trump declared victory in the 2024 presidential election after winning the key battleground states.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>FOXO Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NASDAQ">FOXO</a>) shares shot up 171% to $0.3718.</li>
<li>Shares of Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) got a boost, surging 110% to $8.82 after the company announced the issuance of a U.S. patent covering an IL-18 variant into two novel immunotherapeutic drug candidates.</li>
<li>Trilogy Metals Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMQ#NYSE">TMQ</a>) shares were also up, gaining 73% to $0.9835.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) shares dropped 42% to $4.12.</li>
<li>Shares of Zoomcar Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) were down 40% to $7.94 after the company announced the pricing of $9.15 million private placement.</li>
<li>PACS Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACS#NYSE">PACS</a>) was down, falling 35% to $19.14 after the company announced postponement of third-quarter results and disclosure on civil investigative demands from the federal government.</li>
</ul>
Commodities In commodity news, oil traded down 0.7% to $71.50 while gold traded down 2.8% at $2,672.20.
Silver traded down 4.8% to $31.215 on Wednesday, while copper fell 4.6% to $4.2690.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 fell 0.6%, Germany's DAX dipped 1.2% and France's CAC 40 fell 0.8%. Spain's IBEX 35 Index fell 3.1%, while London's FTSE 100 fell 0.3%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 gaining 2.61%, Hong Kong's Hang Seng Index falling 2.23%, China's Shanghai Composite Index falling 0.09% and India's BSE Sensex gaining 1.13%.
Economics
U.S. mortgage applications fell by 10.8% from the previous week in the week ended Nov. 1.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41773566/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-3-dividend-yie">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

FOXO

NOVA

PACS

SONN

ZCAR

Dow Jumps Over 1,200 Points; Donald Trump Wins White House

Wells Fargo analyst Stephen Baxter maintains Universal Health Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) with a Overweight and raises the price target from $275 to $285.

Wells Fargo Maintains Overweight on Universal Health Servs, Raises Price Target to $285

RBC Capital analyst Greg Pardy maintains Imperial Oil (TSX:<a class="ticker" href="https://www.benzinga.com/stock/IMO#TSX">IMO</a>) with a Sector Perform and raises the price target from C$99 to C$101.

TSX:IMO

RBC Capital Maintains Sector Perform on Imperial Oil, Raises Price Target to C$101

RBC Capital analyst Jimmy Shan maintains InterRent REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/IIP#TSX">IIP</a>) with a Outperform and lowers the price target from C$16.5 to C$15.

TSX:IIP

TSX:IIP/UN

RBC Capital Maintains Outperform on InterRent REIT, Lowers Price Target to C$15

CVS Health Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>)&nbsp;reported third-quarter sales of $95.43 billion, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $92.75 billion</a>.&nbsp;
Total revenues increased 6.3%, primarily driven by growth in the Health Care Benefits and Pharmacy &amp; Consumer Wellness segments, partially offset by a decline in the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41769047/cvs-health-corporation-reports-third-quarter-2024-results" rel="noreferrer noopener">Health Services segment</a>.
Adjusted EPS of $1.09 (inline with preliminary guidance of $1.05-$1.10) decreased from $2.21 in the prior year, missing the consensus of $1.53. The fall was primarily due to a decline in the Health Care Benefits segment&#8217;s operating results, which reflects continued utilization pressure and premium deficiency reserves of approximately $1.1 billion, related to anticipated losses in the fourth quarter of 2024 within the Medicare and individual <a target="_blank" href="https://www.benzinga.com/news/24/11/41719665/cvs-health-q3-earnings-preview-can-the-company-overcome-recent-challenges" rel="noreferrer noopener">exchange product lines</a>.
Adjusted operating income decreased 77.5% to $2.55 billion.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/10/41429974/cigna-and-humana-revive-early-merger-talks-after-year-long-pause-as-medicare-cost-pressure-looms" rel="noreferrer noopener">Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms</a>
During the third quarter of 2024, CVS Health <a target="_blank" href="https://www.cvshealth.com/content/dam/enterprise/cvs-enterprise/pdfs/2024/Q3-2024-Earnings-Release.pdf" rel="noreferrer noopener">finalized</a> its restructuring plan and recorded restructuring charges of approximately $1.2 billion, including store impairment charges for additional retail pharmacy stores it plans to close in 2025.
Revenues in the Health Care Benefits segment increased 25.5% to $32.99 billion. The Medical benefit ratio increased to 95.2% from 85.7% a year ago. Medical membership reached 27.1 million.
Health Services segment revenues decreased 5.9% to $44.13 billion. Pharmacy claims processed decreased 16.5%.
Concurrently, CVS&nbsp;Health announced&nbsp;that Prem&nbsp;Shah will be Group President and responsible for the operational performance across CVS Caremark, CVS Pharmacy, and the company&#8217;s <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41769048/cvs-health-announces-leadership-appointments" rel="noreferrer noopener">Healthcare Delivery businesses</a>.
In addition, the company appointed Steve Nelson&nbsp;as President of Aetna. Both appointments are effective today.
Pharmacy &amp; Consumer Wellness segment revenues increased 12.3% to $32.42 billion, primarily driven by increased prescription volume, including increased contributions from vaccinations and pharmacy drug mix.
In October, CVS Health appointed David Joyner as its new president and CEO, replacing&nbsp;Karen Lynch amid the company&#8217;s&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41398693/cvs-health-appoints-david-joyner-president-and-chief-executive-officer" rel="noreferrer noopener">ongoing financial struggles</a>.
The company also withdrew the 2024 guidance provided in the <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41399396/pharmacy-retailer-cvs-health-backs-away-from-annual-forecast-names-new-ceo" rel="noreferrer noopener">second-quarter earnings release</a>.
Price Action:&nbsp;CVS stock is up 11.30% at $61.60&nbsp;at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41754167/why-is-astrazeneca-stock-sinking-on-tuesday" target="_blank" rel="noreferrer noopener">Why Is AstraZeneca Stock Sinking On Tuesday?</a></li>
</ul>
Image via Shutterstock

Large Cap

Guidance

Health Care

Movers

CVS Health Stock Jumps After Mixed Q3 Earnings, Takes $1.2 Billion Restructuring Charges Hit

RBC Capital analyst Irene Nattel maintains Pet Valu Hldgs (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PET#TSX">PET</a>) with a Outperform and raises the price target from C$34 to C$35.

TSX:PET

RBC Capital Maintains Outperform on Pet Valu Hldgs, Raises Price Target to C$35

WIIM

BABA

BIDU

Citigourp Global Markets 2% Protected Notes Linked To The Djia

XPEV

Shares of US-listed Chinese stocks are trading higher after Donald Trump was elected president of the United States, which could raise concerns over potential tariffs and US-China tensions.

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Overweight and raises the price target from $195 to $205.

Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $205

Warren Buffett, one of the world&#8217;s most successful investors, has shared plenty of advice over his long career. But one <a href="https://www.benzinga.com/news/23/07/33245523/warren-buffetts-no-1-investing-rule-dont-lose-money-practical-advice-for-a-billionaire-but-can-regul">piece of advice</a> stands out as his top rule: &#8220;The first rule of investment is don&#8217;t lose money.&#8221; And if you ask about the second rule? &#8220;Don&#8217;t forget the first.&#8221; According to Buffett, that&#8217;s all you need to know.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">1. Warren Buffett "Rule no.1 is don't lose and the second rule is never forget rule 1." &#x1f410; <a href="https://t.co/x0hEOgxVJ4">pic.twitter.com/x0hEOgxVJ4</a>
&mdash; Oliver &#x7C; MMMT Wealth (CPA) (@MMMTwealth) <a href="https://twitter.com/MMMTwealth/status/1850983304167571542?ref_src=twsrc%5Etfw">October 28, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
<li>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a></li>
</ul>
It might sound simple — even a bit obvious. After all, who wants to lose money? But Buffett's point is more profound than it might first appear. <a href="https://www.benzinga.com/news/24/09/41091380/warren-buffet-tells-investors-to-give-up-on-me-vs-stock-approach-what-tells-you-whether-you-should-k">His investment philosophy</a> is about protecting what you already have. If you lose a big chunk of your investment, you need a huge return just to get back to where you started.&nbsp;
For example, when a stock drops by a big margin, it requires an even greater gain just to get back to its original value. It's much easier to prevent these kinds of losses in the first place than to claw your way back from them.&nbsp;
Of course, saying &#8220;don't lose money&#8221; is easier than actually following through, especially with the ups and downs of the stock market. But there are practical strategies investors can use to help follow Buffett&#8217;s rule.
See Also: This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's an opportunity to invest at $1,000 for only $0.50/share today.</a>
You lower the chance of suffering a significant loss on any one investment by <a href="https://www.benzinga.com/money/how-to-diversify-your-portfolio">distributing your funds over several stocks or sectors</a>. Your portfolio can still be balanced even if one or two stocks do not perform well.
Buffett is known for investing in businesses with <a href="https://www.benzinga.com/startups/24/10/41252767/warren-buffetts-timeless-advice-is-to-invest-in-stocks-that-youd-be-perfectly-happy-to-hold-if-the-m">strong fundamentals</a> that he believes will be successful for many years to come. He prefers companies with a competitive edge, solid management, and products people will continue to buy. Instead of chasing the cheapest stocks, he looks for good companies at reasonable prices.
The market can be a rollercoaster, and emotions like fear or greed often cause people to make costly mistakes. Buffett's approach is to stay calm when others are panicking and to make decisions based on logic, not emotion.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
It's worth noting that even Warren Buffett has lost money, and he has been open about what he thinks are his biggest investment mistakes. He has also stated that one of his worst missteps was purchasing Berkshire Hathaway, a textile company that was initially in decline. Nevertheless, Buffett has been successful over the long term despite these setbacks because he is focused on limiting losses and learning from his mistakes.
<h2 class="wp-block-heading">Alternative Opinions</h2>
On the other hand, some investors think that taking measured risks, even at the expense of occasional losses, is a necessary component of attaining sizable returns, even if Buffett&#8217;s advice to avoid losses is generally accepted. <a href="https://www.benzinga.com/personal-finance/24/06/39360926/diversification-thats-for-idiots-mark-cuban-slams-warren-buffetts-investment-strategy-i-think-bu">Mark Cuban, for example, once said</a>, &#8220;Diversification, that&#8217;s for idiots&#8221; and that &#8220;buy and hold is a crock of s&#x2A;&#x2A;&#x2A;.&#8221;
Plus, startups, emerging technologies, and high-growth companies often come with higher risk but also the potential for substantial gains — something that Buffett's cautious approach might miss.
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"> You can still get 4,000 of its pre-IPO shares for just $1,000</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Startups

'The First Rule Of Investment Is Don't Lose,' Says Warren Buffett. The Second Rule? Don't Forget The First — 'That's All The Rules'

In the current session, SBA Comms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) is trading at $218.54, after a 4.30% drop. Over the past month, the stock fell by 7.45%, and in the past year, by 0.22%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1730906184_0.png" alt="Past Year Chart" />

<h3>A Look at SBA Comms P/E Relative to Its Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
SBA Comms has a lower P/E than the aggregate P/E of 52.76 of the Specialized REITs industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1730906184_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Comments

Universal Music Group

Vendite allo scoperto

Universal Music Group (OTC:UNVGY) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO